Cargando…
Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models
We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalia...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218229/ https://www.ncbi.nlm.nih.gov/pubmed/32420409 http://dx.doi.org/10.1016/j.omtm.2020.04.017 |
_version_ | 1783532755961774080 |
---|---|
author | Bozza, Matthias Green, Edward W. Espinet, Elisa De Roia, Alice Klein, Corinna Vogel, Vanessa Offringa, Rienk Williams, James A. Sprick, Martin Harbottle, Richard P. |
author_facet | Bozza, Matthias Green, Edward W. Espinet, Elisa De Roia, Alice Klein, Corinna Vogel, Vanessa Offringa, Rienk Williams, James A. Sprick, Martin Harbottle, Richard P. |
author_sort | Bozza, Matthias |
collection | PubMed |
description | We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalian S/MAR element can provide persistent mitotic stability over hundreds of cell divisions, resisting epigenetic silencing and thereby allowing sustained transgene expression. The composition of the original S/MAR vectors does present some inherent limitations that can provoke cellular toxicity. Herein, we present a new system, the nano-S/MAR, which drives higher transgene expression and has improved efficiency of establishment, due to the minimal impact on cellular processes and perturbation of the endogenous transcriptome. We show that these features enable the hitherto challenging genetic modification of patient-derived cells to stably restore the tumor suppressor gene SMAD4 to a patient-derived SMAD4 knockout pancreatic cancer line. Nano-S/MAR modification does not alter the molecular or phenotypic integrity of the patient-derived cells in cell culture and xenograft mouse models. In conclusion, we show that these DNA vectors can be used to persistently modify a range of cells, providing sustained transgene expression while avoiding the risks of insertional mutagenesis and other vector-mediated toxicity. |
format | Online Article Text |
id | pubmed-7218229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-72182292020-05-15 Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models Bozza, Matthias Green, Edward W. Espinet, Elisa De Roia, Alice Klein, Corinna Vogel, Vanessa Offringa, Rienk Williams, James A. Sprick, Martin Harbottle, Richard P. Mol Ther Methods Clin Dev Article We describe herein non-integrating minimally sized nano-S/MAR DNA vectors, which can be used to genetically modify dividing cells in place of integrating vectors. They represent a unique genetic tool, which avoids vector-mediated damage. Previous work has shown that DNA vectors comprising a mammalian S/MAR element can provide persistent mitotic stability over hundreds of cell divisions, resisting epigenetic silencing and thereby allowing sustained transgene expression. The composition of the original S/MAR vectors does present some inherent limitations that can provoke cellular toxicity. Herein, we present a new system, the nano-S/MAR, which drives higher transgene expression and has improved efficiency of establishment, due to the minimal impact on cellular processes and perturbation of the endogenous transcriptome. We show that these features enable the hitherto challenging genetic modification of patient-derived cells to stably restore the tumor suppressor gene SMAD4 to a patient-derived SMAD4 knockout pancreatic cancer line. Nano-S/MAR modification does not alter the molecular or phenotypic integrity of the patient-derived cells in cell culture and xenograft mouse models. In conclusion, we show that these DNA vectors can be used to persistently modify a range of cells, providing sustained transgene expression while avoiding the risks of insertional mutagenesis and other vector-mediated toxicity. American Society of Gene & Cell Therapy 2020-04-25 /pmc/articles/PMC7218229/ /pubmed/32420409 http://dx.doi.org/10.1016/j.omtm.2020.04.017 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bozza, Matthias Green, Edward W. Espinet, Elisa De Roia, Alice Klein, Corinna Vogel, Vanessa Offringa, Rienk Williams, James A. Sprick, Martin Harbottle, Richard P. Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title_full | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title_fullStr | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title_full_unstemmed | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title_short | Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models |
title_sort | novel non-integrating dna nano-s/mar vectors restore gene function in isogenic patient-derived pancreatic tumor models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218229/ https://www.ncbi.nlm.nih.gov/pubmed/32420409 http://dx.doi.org/10.1016/j.omtm.2020.04.017 |
work_keys_str_mv | AT bozzamatthias novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT greenedwardw novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT espinetelisa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT deroiaalice novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT kleincorinna novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT vogelvanessa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT offringarienk novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT williamsjamesa novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT sprickmartin novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels AT harbottlerichardp novelnonintegratingdnananosmarvectorsrestoregenefunctioninisogenicpatientderivedpancreatictumormodels |